IMAT - ultrafast tomography for coronary artery disease Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TA2K who wrote (3679)	5/10/2001 1:44:20 AM
From: TA2K	Read Replies (1) of 3725

The real 'dead end'.... ...is the misguided policy of not issuing sales PRs. Imatron used to do that. Then they stopped. Sooooo.... if you *know* that no Imatron sales PRs will be issued for the next two months, what would you expect to happen to price during the next two months? Folks, this is not rocket science. That lack of sales PRs *completely* changes the dynamics of IMAT. It truly has created a dead end here. So sad. Moronic decision on Meyer's part. And he doesn't even get it. Do you??? Be tuned!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next